# Atovaquone

NDC: 31722-629
Generic name: Atovaquone
Labeler / Manufacturer: Camber Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20181011

FDA application: ANDA210692

## Active ingredients

- ATOVAQUONE: 750 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"31722-629"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=31722-629
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2445304e-4b4e-4358-b098-31f3c49c52ef